TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
Nobel Biocare Norge AS
Closing information (x1000 EUR)
| Closing information | 2023/12 | 2022/12 | 2021/12 |
| Turnover |
2,549
|
3,081
|
3,417 |
| Financial expenses |
85
|
43
|
19 |
| Earnings before taxes |
-59
|
12
|
149 |
| Total assets |
2,703
|
2,844
|
3,021 |
| Current assets |
1,042
|
1,085
|
1,173 |
| Current liabilities |
1,967
|
2,009
|
2,148 |
| Equity capital |
736
|
836
|
873 |
| - share capital |
9
|
9
|
10 |
Financial ratios
| Fiscal year | 2023/12 | 2022/12 | 2021/12 |
| Solvency |
27.2%
|
29.4%
|
28.9% |
| Turnover per employee | |||
| Profit as a percentage of turnover |
-2.3%
|
0.4%
|
4.4% |
| Return on assets (ROA) |
1.0%
|
1.9%
|
5.6% |
| Current ratio |
53.0%
|
54.0%
|
54.6% |
| Return on equity (ROE) |
-8.0%
|
1.4%
|
17.1% |
| Change turnover |
-336
|
-157
|
693 |
| Change turnover % |
-12%
|
-5%
|
25% |
| Chg. No. of employees | |||
| Chg. No. of employees % |
Total value of public sale
| Fiscal year | 2023/12 | 2022/12 | 2021/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.